Topics

552 Fully Vaccinated Oregon Residents Died Of COVID-19, Half Received Pfizer Vaccine
A Novel Practical Approach for Directly Assessing COVID-19 Vaccine Efficacy against Hospitalization
A Systematic Review of COVID-19 Vaccine-Induced Takotsubo Cardiomyopathy: A 2023 Update
Acute-onset chronic inflammatory demyelinating polyneuropathy following AstraZeneca COVID-19 vaccine: a case report
All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Aged 25-44 Years, March-July 2020
An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021
Appendix 1: estimation of number needed to vaccinate to prevent a COVID-19 hospitalisation for primary vaccination, booster vaccination (3rd dose), autumn 2022 and spring 2023 booster for those newly in a risk group
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
Biden's Bounty on Your Life: Hospitals' Incentive Payments for COVID-19
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19
Case report: Varicella zoster virus encephalitis following COVID-19 vaccination in an immunocompetent individual
CNS Demyelination Syndromes Following COVID-19 Vaccination: A Case Series
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
Correlation Between 3790 Quantitative Polymerase Chain Reaction - Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates
Covid Whistleblowers, What the Nurses Saw
COVID-19 in Northern Ireland: Vaccination Status of Deaths and Hospitalisations — Updated to Include Weeks 51 to 2 (20th December 2021 to 16th January 2022)
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
Covid-19 Rapport om omikronvarianten
COVID-19 Vaccination-Induced Cardiomyopathy Requiring Permanent Left Ventricular Assist Device
COVID-19 Vaccination-Related Myocarditis: What We Learned From Our Experience and What We Need to Do in The Future
COVID-19 Vaccine Breakthrough Case Investigation and Reporting
COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021
COVID-19 vaccine effectiveness updates - 24 February 2023 (CDC)
COVID-19 vaccine surveillance report, Week 13
COVID-19 vaccine surveillance report, Week 2
COVID-19 vaccine surveillance report, Week 48
COVID-19 Vaccine-Related Myocarditis: A Descriptive Study of 40 Case Reports
Current Hospital Capacity Estimates - Snapshot
Deaths Following C-19 Vaccination: An open letter from NZDSOS on the Need to Investigate Deaths Following Vaccination
Dr. Peter McCullough presentation at 78th Annual Meeting of Association of American Physicians and Surgeons (AAPS)
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
Estimated COVID-19 Burden
Estimating the burden of SARS-CoV-2 in France
Evaluating Data Integrity and Reporting Challenges in Public Health: Lessons from COVID-19 Data Collection in Washington State
Frequency and Associations of Adverse Reactions of COVID19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States
From risk to resilience: An equity approach to COVID-19 - Chief Public Health Officer of Canada's Report on the State of Public Health in Canada 2020
Guillain-Barré syndrome associated with SARS-CoV-2 vaccination: how is it different? a systematic review and individual participant data meta-analysis
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Legal Letter on Behalf of Physicians Regarding Covid-19 Vaccine Injuries (to heads of the DHHS, CDC, and FDA)
Letter to the Editor: Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
Medical Hypothesis: Respiratory epidemics and pandemics without viral transmission
My Life in the Thrill Kill Medical Cult
Neurologic Sequela of COVID-19: Guillain-Barré Syndrome Following Johnson & Johnson COVID-19 Vaccination
New COVID-19 Treatments Add-On Payment (NCTAP)
NHS key statistics: England
No difference in risk of hospitalisation between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway
Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021
NSW COVID-19 Weekly Data Overview: Epidemiological weeks 51 and 52, ending 31 December 2022
1468